Tbio GTSE1 G2 and S phase-expressed protein 1

Protein Summary

Description

May be involved in p53-induced cell cycle arrest in G2/M phase by interfering with microtubule rearrangements that are required to enter mitosis. Overexpression delays G2/M phase progression. The protein encoded by this gene is only expressed in the S and G2 phases of the cell cycle, where it colocalizes with cytoplasmic tubulin and microtubules. In response to DNA damage, the encoded protein accumulates in the nucleus and binds the tumor suppressor protein p53, shuttling it out of the nucleus and repressing its ability to induce apoptosis. [provided by RefSeq, Jul 2008]

Uniprot Accession IDs

• Q9NYZ3
• B0QYM3
• Q20WK2
• Q53GX5
• Q5R3I6
• Q6DHX4
• Q9BRE0
• Q9UGZ9
• Q9Y557
• GTSE-1

Gene Name

• GTSE1

Ensembl ID

• ENST00000454366
• ENSP00000415430
• ENSG00000075218

Symbol

• B99

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
drug perturbation	0.96
transcription factor perturbation	0.96
histone modification site profile	0.86
protein complex	0.82
co-expressed gene	0.69

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 43.03   (req: < 5)

Gene RIFs: 25   (req: <= 3)

Antibodies: 247   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 43.03   (req: >= 5)

Gene RIFs: 25   (req: > 3)

Antibodies: 247   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 7

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0